Best Medical Cannabis Clinics Australia — Top 5 Reviewed & Compared
The complete independent guide to Australian medical cannabis clinics — five of the most established telehealth clinics reviewed in full, with pricing breakdowns, AHPRA registration, conditions treated, ownership structure, and the honest patient journey explained.
Medical Cannabis in Australia — What You Need to Know Before Choosing a Clinic
Medical cannabis became legal in Australia in 2016, when the Narcotic Drugs Act 1967 was amended to permit licensed cultivation, production, and prescribing for medicinal purposes. Since then, access has grown rapidly through a network of telehealth clinics — some estimates put the number of Australians using medicinal cannabis at over a million, served by a mix of large pharma-backed platforms and smaller independent clinics.
Only two medicinal cannabis products are actually approved by the Therapeutic Goods Administration (TGA) for supply in Australia: Sativex (nabiximols, approved for MS spasticity, not PBS-subsidised) and Epidyolex (CBD, PBS-listed for Dravet syndrome, not for Lennox-Gastaut syndrome). Every other cannabis product prescribed in Australia — well over 99% of what is actually dispensed — is legally classed as "unapproved," accessed through the TGA's Special Access Scheme (patient-specific approval) or the Authorised Prescriber pathway (which lets an approved doctor prescribe to a class of patients without seeking approval each time). This does not mean the products are illegal — it means the TGA has not itself assessed their safety, quality, or effectiveness before they reach a patient.
The five clinics reviewed in this guide — Alternaleaf, Medio, Polln, Australian Access Clinics, and Cannalink Clinic — represent a genuine cross-section of the Australian market: from the largest pharma-backed telehealth network to smaller independent and family-owned clinics. Between them they illustrate the full range of pricing models, clinical approaches, and ownership structures a patient will encounter.
A Note on Industry Scrutiny
The Australian medical cannabis telehealth sector has faced genuine, publicly documented scrutiny. A 2025 University of Queensland study found that a significant proportion of Australian medicinal cannabis websites did not fully meet regulatory advertising guidelines — a notable issue given that advertising prescription medicines directly to consumers is illegal in Australia, which is why many clinics market themselves using terms like "alternative therapy" or "natural medicine" rather than naming cannabis directly. Separately, a 2026 CHOICE investigation found that several major telehealth clinics are commercially linked to the same companies that supply the cannabis products being prescribed, and documented at least one doctor consultation lasting under four minutes before a prescription was issued. The Australian Health Practitioner Regulation Agency (AHPRA) has taken regulatory action against more than 80 practitioners over medicinal cannabis prescribing standards since 2019.
This does not mean medical cannabis access in Australia is unsafe or illegitimate — for many patients with genuine, difficult-to-treat conditions it is a real and valuable treatment pathway. But it is worth knowing, before choosing a clinic, whether that clinic is owned by or commercially linked to a cannabis supplier, and how long a typical doctor consultation actually runs. Both factors are noted in the reviews below.
How Australian Medical Cannabis Prescribing Works
Prescriptions must be issued by an AHPRA-registered doctor, typically operating under Authorised Prescriber status or applying through the Special Access Scheme Category B for each patient. Most telehealth clinics use a two-stage model — an initial nurse or intake screening, followed by a doctor consultation — though consultation length and clinical depth vary significantly between clinics, as the industry scrutiny above illustrates. There is no requirement for a GP referral at any of the five clinics reviewed here.
Medicinal cannabis is not listed on the Pharmaceutical Benefits Scheme (PBS) except for Epidyolex in Dravet syndrome, meaning almost all patients pay the full private cost of both the consultation and the medication. Medication is dispensed through a partner pharmacy and delivered to the patient's home, typically within days of a prescription being issued.
Australian Medical Cannabis Clinics — Head to Head Comparison
The table below compares all five clinics across the criteria that matter most to Australian patients — pricing, ownership structure, conditions coverage, and key service features.
| Feature | Alternaleaf | Medio | Polln | Aus. Access Clinics | Cannalink Clinic |
|---|---|---|---|---|---|
| Parent company | Montu Group (est. 2019) | Independent | Nectar Brands | Independent | Independent, family-owned |
| Vertically integrated | ❌ Owns pharmacy + platform | ✅ No supplier link | ⚠️ Linked to Cultiva supplier | ✅ No supplier link | ✅ No supplier link |
| Initial consultation | Free nurse screen + doctor consult | $89 | ~$99 (30-min consult) | $99 (reduced from $150) | $69 |
| Follow-up consultation | Included in ongoing care | Standard fee applies | Standard fee applies | $79 | $39 |
| Concession discount | ⚠️ Varies | ⚠️ Varies | ⚠️ Varies | ⚠️ Varies | ✅ Extra $10 off |
| GP referral required | ❌ No | ❌ No | ❌ No | ❌ No | ❌ No |
| Consultation length (reported) | ⚠️ As short as ~3.5 min reported | ✅ Longer, doctor-led | ✅ ~30 minutes | ⚠️ Varies by doctor | ⚠️ Not independently reported |
| Same-day appointments | ✅ Where available | ⚠️ Standard booking | ⚠️ Standard booking | ⚠️ Within 1-2 business days | ⚠️ Within 1-2 business days |
| Patient volume | 150,000+ patients/year (self-reported) | Not disclosed | Not disclosed | 25,000+ patients | Not disclosed |
| Medication delivery | ✅ Via Montu pharmacy | ✅ Via partner pharmacy | ✅ Via partner pharmacy | ✅ Free via partner dispensary | ✅ Via partner pharmacy |
| AHPRA registered doctors | ✅ Yes | ✅ Yes | ✅ Yes | ✅ Yes | ✅ Yes |
| Telehealth only | ✅ Fully online | ✅ Fully online | ✅ Fully online | ✅ Phone/video only | ✅ Fully online |
The 5 Best Medical Cannabis Clinics in Australia — Full Reviews
Each clinic below has been evaluated on pricing transparency and value, ownership and commercial structure, conditions coverage, patient journey experience, and independent reporting where available, including the 2025-2026 industry scrutiny referenced above.
Alternaleaf
Alternaleaf is the clinic arm of Montu Group, founded in 2019 and now Australia's largest medical cannabis telehealth provider by a significant margin — Montu reports serving over 150,000 patients annually across its network, with over 120 AHPRA-registered practitioners. The patient journey starts with a free questionnaire and nurse consultation, followed by a doctor appointment to determine clinical suitability, all managed through Montu's Circuit patient portal.
The scale is Alternaleaf's core advantage — same-day nurse consultations where available, a large practitioner base reducing wait times, and an established pharmacy and delivery network (Montu's Leafio distribution system) that gets medication to patients quickly. The trade-off is structural: Montu owns Alternaleaf (the clinic), Circuit (the patient portal), and a dispensing pharmacy, meaning the same company profits from the appointment and every prescription filled. A 2026 CHOICE investigation reported one Alternaleaf doctor consultation lasting approximately three and a half minutes before a cannabis prescription was issued; Alternaleaf told CHOICE the practitioner involved had been stood down and described the case as an outlier pending a clinical audit.
For patients who simply want the fastest, largest-scale route into the system, Alternaleaf delivers on that promise. Patients who want to be certain their doctor has no commercial link to the product they are prescribing should weigh the vertical integration point carefully.
Conditions Treated
Pricing Detail
Initial screen: Free nurse consultation to assess eligibility before a paid doctor appointment is booked.
Doctor consultation and ongoing care: Fees are not published as a flat rate on Alternaleaf's site and are confirmed during the booking process; concession card holders receive a stated discount on consultations.
Medication: Dispensed through Montu's own pharmacy network, priced per product and not included in the consultation fee.
✅ Strengths
- ✅ Largest patient network in Australia — 150,000+ patients per year
- ✅ Same-day nurse consultations where available
- ✅ Over 120 AHPRA-registered practitioners reduces wait times
- ✅ Integrated pharmacy and distribution network for fast delivery
- ✅ Free initial nurse screening before any paid appointment
- ✅ Concession card discounts available
⚠️ Weaknesses
- ⚠️ Vertically integrated — Montu owns the clinic, portal, and dispensing pharmacy
- ⚠️ A 2026 CHOICE investigation documented a doctor consultation of roughly 3.5 minutes before prescribing
- ⚠️ High patient volume model may mean less individualised time per consultation versus boutique clinics
- ⚠️ Consultation and subscription pricing not transparently published upfront on the public site
- ⚠️ AHPRA has taken action against 80+ practitioners industry-wide since 2019 for cannabis prescribing standards — a sector-wide risk factor relevant to the largest player
Patient Reviews
Patient feedback on Alternaleaf's own site frequently praises the ease of the online process and the friendliness of nurse and doctor staff, particularly for patients less confident with technology. Independent commentary is more mixed, with the CHOICE investigation specifically raising concerns about consultation depth and conflict-of-interest disclosure.
Medio
Medio positions itself explicitly against the vertically integrated model that dominates the Australian market — it is independently owned, with no commercial relationship between its doctors and any cannabis manufacturer, brand, or dispensary. Medio markets this directly, publishing side-by-side comparisons against Alternaleaf and Montu that highlight the structural difference: at Medio, the consultation fee is the only transaction between patient and doctor, and the prescribing decision carries no financial incentive toward any particular product or pharmacy.
Consultations at Medio are doctor-led from the very first appointment rather than starting with a nurse screen, and are reported to run longer than the shortest consultations documented at larger competitors. The initial consultation costs $89 — positioned in the mid-range compared to the five clinics reviewed here.
Conditions Treated
Pricing Detail
Initial consultation: $89 — doctor-led telehealth appointment, no preceding nurse screen required.
Follow-ups: Standard consultation fee applies; Medio does not operate a low-cost loss-leader subscription model in the way some vertically integrated competitors do.
Medication: Filled through an independent pharmacy of the patient's choosing rather than a clinic-owned dispensary — patients are not funnelled toward an in-house pharmacy.
✅ Strengths
- ✅ No ownership link between the clinic and any cannabis manufacturer or pharmacy
- ✅ Doctor-led consultations from the first appointment — no nurse-first triage
- ✅ Transparent, published pricing at $89 for initial consultation
- ✅ Patients can use their own pharmacy rather than a clinic-owned dispensary
- ✅ Explicitly markets its independence as a point of differentiation
⚠️ Weaknesses
- ⚠️ Smaller patient volume and brand recognition than Alternaleaf
- ⚠️ No published free initial nurse screen — every appointment is a paid consultation
- ⚠️ Independent review volume (Trustpilot, Google) is limited compared to larger competitors
- ⚠️ No large-scale integrated distribution network — delivery speed depends on the chosen pharmacy
Patient Reviews
Medio's marketing centres heavily on the independence message, and this appears to resonate with patients specifically seeking a second opinion or an alternative after experiences at vertically integrated clinics — a portion of Medio's stated audience are patients transferring from Alternaleaf or Montu-affiliated clinics.
Polln
Polln positions itself around depth of care rather than volume — a 30-minute, in-depth consultation directly with an AHPRA-registered doctor, the ability to choose and keep the same doctor across follow-ups, and a stated policy of never marking up medicines so treatment decisions are "based on clinical need — not cost, pressure or incentive." Patients manage medications, follow-ups, and deliveries through the Polln patient portal, and unlimited nurse and pharmacy support is available Monday to Friday at no extra cost.
One point of transparency worth noting: Polln is owned by Nectar Brands, which also owns the cannabis supplier Cultiva. When asked by CHOICE about this structure, Nectar Brands stated that Polln operates "exclusively as a telehealth platform" and should not be conflated with any other entity it owns. Patients who value Polln's stated no-markup, product-agnostic prescribing policy should weigh this ownership relationship alongside that commitment.
Conditions Treated
Pricing Detail
Initial consultation: Approximately $99 for a 30-minute in-depth doctor consultation — longer than the standard telehealth appointment length at most competitors.
Ongoing support: Free, unlimited nurse and pharmacy support Monday to Friday included at no additional charge.
Medication: Polln states it does not mark up medicines above cost, though patients should independently verify current pricing given the ownership link to a cannabis supplier noted above.
✅ Strengths
- ✅ Longest standard consultation of the clinics reviewed — 30 minutes, doctor-led
- ✅ Continuity of care — patients choose and keep their preferred doctor
- ✅ Free unlimited nurse and pharmacy support included
- ✅ Stated policy against marking up medicine pricing
- ✅ Strong emphasis on a considered, non-volume-driven clinical approach
⚠️ Weaknesses
- ⚠️ Owned by Nectar Brands, which also owns cannabis supplier Cultiva — a disclosed but real commercial link
- ⚠️ Premium consultation length comes with a premium price versus budget clinics
- ⚠️ Smaller network than Alternaleaf, potentially longer appointment availability windows
- ⚠️ Product-agnostic claims are self-reported rather than independently audited
Patient Reviews
Patient feedback specifically highlights the unhurried nature of consultations and the feeling of being heard, in contrast to the rushed-consultation criticism levelled at higher-volume competitors.
Australian Access Clinics
Australian Access Clinics describes itself as Australia's longest-serving alternative healthcare clinic, serving more than 25,000 patients nationwide via telephone-only telehealth appointments. Its pricing is unusually transparent for the sector — a published $99 initial consultation (discounted from a standard $150) and $79 follow-ups, with an explicit no-hidden-fees policy: no dispensing fees, no administrative application fees, and a guarantee that patients pay no more than recommended retail price through its preferred dispensary partners.
The clinic publishes concrete estimated medication costs on its own site — a genuinely useful transparency feature most competitors do not offer — starting from approximately $5/gram for dried flower for vaporisation, $55 for a 1g vape cartridge, $59 for oral oil formulations, and $49 for gummies or pastilles.
Conditions Treated
Pricing Detail
Initial consultation: $99 (reduced from a standard $150 fee) — telephone appointment with an AHPRA-registered doctor.
Follow-up consultations: $79 to monitor and adjust the treatment plan.
Medication: Published guide pricing — approximately $5/gram dried herb, $55 per 1g vape cartridge, $59 for oils, $49 for gummies/pastilles — through preferred dispensary partners at guaranteed RRP with free shipping.
✅ Strengths
- ✅ Unusually transparent published pricing, including medication cost estimates
- ✅ No hidden dispensing or administrative fees, guaranteed RRP pricing
- ✅ Long operating history — positions itself as Australia's longest-serving alternative health clinic
- ✅ 25,000+ patients served with a genuine independent review base (4.2★, 144 Birdeye reviews)
- ✅ Free shipping via partner dispensary
⚠️ Weaknesses
- ⚠️ Telephone-only appointments — no video consultation option
- ⚠️ Some independent reviews cite long waiting times for appointments
- ⚠️ Mixed reports on reception/administrative responsiveness
- ⚠️ Smaller patient base than Alternaleaf, potentially longer scheduling windows at peak times
Patient Reviews
Independent reviews on Birdeye and similar platforms consistently highlight specific doctors by name for empathetic, thorough consultations, and praise the straightforward booking and telehealth process. The most commonly cited criticism is appointment wait times during busier periods, and occasional inconsistency from reception staff.
Cannalink Clinic
Cannalink Clinic is a family-owned, doctor-led telehealth clinic built around a simple pitch: ethical, patient-first treatment at the lowest published fees of any clinic in this guide. The intake process — a free online screening taking under five minutes — is reviewed by the clinical team, with most patients contacted within one business day and a telehealth appointment scheduled within two.
Cannalink's pricing is the most affordable of the five clinics reviewed here: a $69 initial consultation and $39 follow-ups, with an additional $10 off for eligible concession card holders (Health Care Card, Seniors Health and Pensioner Card, or DVA card). Afterpay is available for patients who want to spread the cost of their initial consultation.
Conditions Treated
Pricing Detail
Initial consultation: $69 — the lowest published rate among the five clinics in this guide.
Follow-up consultations: $39, with a further $10 discount for concession card holders.
Medication: Dispensed through partner pharmacies, priced separately from the consultation fee.
✅ Strengths
- ✅ Cheapest published consultation fees of any clinic reviewed — $69 initial, $39 follow-up
- ✅ Independently, family-owned — no disclosed supplier ownership link
- ✅ Fast intake turnaround — contact within 1 business day, appointment within 2
- ✅ Concession card discounts and Afterpay available
- ✅ No GP referral required
⚠️ Weaknesses
- ⚠️ Smaller operation with less publicly available independent review data than larger competitors
- ⚠️ Patient volume and practitioner headcount not disclosed
- ⚠️ Narrower published conditions list than the largest clinics
- ⚠️ Consultation length and depth not independently reported or verified
Patient Reviews
Cannalink markets itself specifically on affordability and a personalised, non-corporate approach, positioning itself against what it describes as a "one-size-fits-all" industry model.
Common Medical Cannabis Qualifying Conditions in Australia
Medical cannabis in Australia can be prescribed for a wide range of conditions using unapproved products at the doctor's clinical discretion, alongside two conditions with genuine TGA-approved, evidence-assessed products. The conditions below are the most commonly treated across the five clinics reviewed in this guide.
True Annual Cost of Medical Cannabis in Australia — Full Breakdown
Understanding the real annual cost of Australian medical cannabis requires separating clinic fees from medication costs. Because almost no products are PBS-subsidised, medication cost dominates the total — clinic fees are typically the smaller component regardless of which clinic a patient chooses.
| Clinic | Initial Consultation | Follow-Up Fee | Medication (est. monthly) | Estimated Annual Total |
|---|---|---|---|---|
| Alternaleaf | Free nurse + doctor consult | Included in ongoing care | $150-$450 | $1,800-$5,400 |
| Medio | $89 | Standard fee | $150-$400 | $2,000-$5,000 |
| Polln | ~$99 | Standard fee | $150-$400 | $2,000-$5,000 |
| Australian Access Clinics | $99 | $79 (approx. 4x/year) | $100-$350 | $1,415-$4,415 |
| Cannalink Clinic | $69 | $39 (approx. 4x/year) | $100-$350 | $1,285-$4,285 |
Medication cost is the dominant variable — clinic fees at the budget end ($69-$99 initial, $39-$79 follow-up) are modest next to the ongoing monthly medication spend. Because the government has stated it has no control over the price a supplier charges for unapproved medicines, and because there is no PBS subsidy pathway for the vast majority of products, the price per gram of prescribed medical cannabis flower in Australia is frequently higher than equivalent lab-tested product from verified delivery services.
Medical Cannabis Prescription vs Recreational Delivery — The Honest Comparison
For many Australians considering the medical route, the honest question is whether the benefits of a formal prescription justify the cost, the ownership-structure considerations discussed above, and the administrative process. The answer depends heavily on individual circumstances.
| Factor | Medical Cannabis Prescription | Leaflybuds Same-Day Delivery |
|---|---|---|
| Legal status | Fully legal — prescribed medicine | Grey market |
| Cost (annual) | $1,285-$5,400+ total | Variable — order as needed |
| Medical oversight | ✅ AHPRA-registered doctor | ❌ No clinical oversight |
| PBS subsidy | ❌ Almost none (Epidyolex/Dravet only) | Not applicable |
| Product quality | Pharmaceutical-grade, GMP-manufactured | Independent COA-tested, lab-verified |
| Speed to access | Days to a few weeks from first consultation | Same-day on pre-2pm orders |
| Strain/product selection | Limited formulary per clinic/pharmacy | Full range of genetics |
| Ownership transparency | ⚠️ Varies — some clinics vertically integrated | Independent of any supplier |
| Employment drug testing | ✅ Prescription provides context | ❌ No legal context |
| Price per gram (flower) | $5+/gram, often higher with clinic markups | Competitive market pricing |
| Delivery discretion | Standard pharmacy packaging | Plain unbranded packaging |
| Repeat customer track record | Ongoing clinical relationship | 10,000+ reviews · loyalty programme |
A formal medical prescription is clearly the right choice for patients with serious, well-documented conditions — particularly conditions with a TGA-approved product (MS spasticity, Dravet syndrome), patients who work in regulated industries needing documented clinical context, or those who need genuine clinical oversight for complex conditions. The legal and clinical protections of a formal prescription are real and meaningful for these patients — and choosing a clinic with transparent ownership and adequate consultation time, as reviewed above, matters.
For recreational cannabis users or patients with mild-to-moderate symptoms who primarily want quality-verified cannabis without the administrative and financial burden of the prescription route, same-day delivery from a verified source like Leaflybuds provides lab-tested product with independent COA documentation at a lower total cost.
Lab-Tested Cannabis — Delivered Same Day
If you are exploring medical cannabis but not ready to commit to the clinic process — or if you want premium lab-tested cannabis without the prescription route — Leaflybuds delivers independently verified THC flower, vapes, pre-rolls, edibles, and concentrates to all Australian postcodes same day.
Premium Lab-Tested Cannabis — Same-Day Delivery
Independent COA on every product. Same-day dispatch before 2pm, Australia Post Express Tracked, plain packaging. 10,000+ verified Australian reviews · 4.70★
Browse Leaflybuds Shop →